VHH antibody, also known as Camelid single domain antibody (sdAb), is the recombinant variable domain derived from camelid heavy-chain-only antibody. This configuration confers some unique properties. The small size and high stability of VHH antibodies make it a promising tool for disease diagnosis and treatment. VHH antibodies can penetrate tissue more easily and target difficult epitopes hidden in the protein structure. Additionally, VHH antibodies express well in many host systems, making it cost-effective for large-scale manufacturing.
Abnova offers the NanoAb™ service for the production of target-specific VHH antibodies from the camelid VHH library. Using advanced camelid VHH library screening technology, we screen the library and isolate the VHH clones for your required antigens. Positive clones are sequenced and validated by ELISA. The selected clones will then be introduced into the mammalian expression vector for scalable VHH antibody production, suitable for many downstream applications. We guarantee the bioactivity of NanoAb™ VHH antibodies expressed in mammalian cells.
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
|
||||||||||||||||||||||||||||
|
||||
CD8A VHH Humanized Monoclonal Antibodies |
||||
|
||||
|
||||
Human EpCAM VHH Phage Supernatant
Mouse CAIX VHH Phage Supernatant
Mouse CD276 VHH Phage Supernatant
Mouse PD-L1 VHH Phage Supernatant
|
- oem@abnova.com
- Global : +886-2-8751-1888 / China: +86-21-51769110